BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28133789)

  • 21. A Comparative Evaluation of Presepsin with Procalcitonin and CRP in Diagnosing Neonatal Sepsis.
    Kumar N; Dayal R; Singh P; Pathak S; Pooniya V; Goyal A; Kamal R; Mohanty KK
    Indian J Pediatr; 2019 Feb; 86(2):177-179. PubMed ID: 29577181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal Evaluation of Plasma Concentrations of Presepsin in Patients after Severe Trauma: A Prospective Observational Study.
    Koch C; Ruhrmann S; Pöhlmann M; Schneck E; Arneth B; Zajonz T; Sander M; Weigand MA; Uhle F
    Surg Infect (Larchmt); 2018 Jul; 19(5):480-487. PubMed ID: 29683405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
    Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P
    World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
    Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
    BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department.
    de Guadiana Romualdo LG; Torrella PE; Acebes SR; Otón MDA; Sánchez RJ; Holgado AH; Santos EJ; Freire AO
    Clin Chim Acta; 2017 Jan; 464():6-11. PubMed ID: 27823951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia.
    Cerasi S; Leardini D; Lisanti N; Belotti T; Pierantoni L; Zama D; Lanari M; Prete A; Masetti R
    Sci Rep; 2023 Apr; 13(1):6464. PubMed ID: 37081067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of presepsin in predicting bacteraemia in elderly patients admitted to the emergency department: prospective study in Japan.
    Imai Y; Taniguchi K; Iida R; Nitta M; Uchiyma K; Takasu A
    BMJ Open; 2019 Dec; 9(12):e030421. PubMed ID: 31843822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
    Kweon OJ; Choi JH; Park SK; Park AJ
    J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis.
    Yoon SH; Kim EH; Kim HY; Ahn JG
    BMC Infect Dis; 2019 Aug; 19(1):760. PubMed ID: 31470804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
    Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
    Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units.
    Takahashi W; Nakada TA; Yazaki M; Oda S
    Shock; 2016 Sep; 46(3):254-60. PubMed ID: 27172160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial.
    Masson S; Caironi P; Spanuth E; Thomae R; Panigada M; Sangiorgi G; Fumagalli R; Mauri T; Isgrò S; Fanizza C; Romero M; Tognoni G; Latini R; Gattinoni L;
    Crit Care; 2014 Jan; 18(1):R6. PubMed ID: 24393424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis.
    Ali FT; Ali MA; Elnakeeb MM; Bendary HN
    Clin Chim Acta; 2016 Sep; 460():93-101. PubMed ID: 27353646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of serum presepsin, procalcitonin, copeptin, and high-sensitivity C-reactive protein for differentiating bacterial infection from disease activity in Egyptian patients with systemic lupus erythematosus.
    AlJarhi UM; Sadek KM; Darwish EM; Elmessiery RM; Salem K; Khalil SA; Seif El Nasr SM; Kamel MF; Hesham D; Fayed A
    Clin Rheumatol; 2021 May; 40(5):1861-1869. PubMed ID: 33111183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis.
    Lu B; Zhang Y; Li C; Liu C; Yao Y; Su M; Shou S
    Am J Emerg Med; 2018 Aug; 36(8):1341-1345. PubMed ID: 29276032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
    von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial measurement of presepsin, procalcitonin, and C-reactive protein in the early postoperative period and the response to antithymocyte globulin administration after heart transplantation.
    Franeková J; Sečník P; Lavríková P; Kubíček Z; Hošková L; Kieslichová E; Jabor A
    Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27859613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
    van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
    Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
    Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
    Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis.
    Bellos I; Fitrou G; Pergialiotis V; Thomakos N; Perrea DN; Daskalakis G
    Eur J Pediatr; 2018 May; 177(5):625-632. PubMed ID: 29476345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.